Schwab Charles Investment Management Inc. boosted its position in shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) by 5.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 131,780 shares of the medical device company’s stock after buying an additional 7,152 shares during the period. Schwab Charles Investment Management Inc. owned approximately 0.31% of K2M Group Holdings worth $2,703,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of KTWO. Legal & General Group Plc raised its position in shares of K2M Group Holdings by 9.1% in the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock worth $138,000 after buying an additional 564 shares in the last quarter. Parkwood LLC purchased a new position in shares of K2M Group Holdings during the first quarter worth approximately $223,000. Paradigm Capital Management Inc. NY purchased a new position in shares of K2M Group Holdings during the first quarter worth approximately $226,000. Trexquant Investment LP purchased a new position in shares of K2M Group Holdings during the first quarter worth approximately $250,000. Finally, 1st Global Advisors Inc. raised its position in shares of K2M Group Holdings by 2.9% in the first quarter. 1st Global Advisors Inc. now owns 13,101 shares of the medical device company’s stock worth $269,000 after buying an additional 369 shares in the last quarter. 98.55% of the stock is currently owned by hedge funds and other institutional investors.

K2M Group Holdings, Inc. (KTWO) traded down 0.34% during mid-day trading on Monday, hitting $23.37. The stock had a trading volume of 72,229 shares. The company’s market cap is $1.01 billion. The firm’s 50-day moving average is $24.00 and its 200 day moving average is $22.03. K2M Group Holdings, Inc. has a 12 month low of $15.45 and a 12 month high of $25.99.

K2M Group Holdings (NASDAQ:KTWO) last issued its quarterly earnings data on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.22) by $0.01. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The company had revenue of $65.70 million for the quarter, compared to the consensus estimate of $66.26 million. During the same period last year, the firm posted ($0.27) EPS. K2M Group Holdings’s revenue for the quarter was up 11.0% on a year-over-year basis. Equities analysts anticipate that K2M Group Holdings, Inc. will post ($0.78) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/08/21/schwab-charles-investment-management-inc-raises-position-in-k2m-group-holdings-inc-ktwo.html.

KTWO has been the topic of a number of research reports. Needham & Company LLC reaffirmed a “buy” rating on shares of K2M Group Holdings in a report on Wednesday, August 2nd. Oppenheimer Holdings, Inc. set a $29.00 price objective on K2M Group Holdings and gave the company a “buy” rating in a report on Wednesday, August 2nd. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $26.00 price objective on shares of K2M Group Holdings in a report on Thursday, July 20th. BidaskClub raised K2M Group Holdings from a “hold” rating to a “buy” rating in a report on Wednesday, July 19th. Finally, Cowen and Company reaffirmed a “buy” rating and issued a $26.00 price objective on shares of K2M Group Holdings in a report on Wednesday, July 19th. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $26.50.

In other K2M Group Holdings news, insider John Philip Md Kostuik sold 50,000 shares of the firm’s stock in a transaction on Thursday, May 25th. The shares were sold at an average price of $22.70, for a total transaction of $1,135,000.00. Following the transaction, the insider now directly owns 199,107 shares of the company’s stock, valued at approximately $4,519,728.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Gregory S. Cole sold 42,947 shares of the firm’s stock in a transaction on Friday, June 16th. The stock was sold at an average price of $22.80, for a total transaction of $979,191.60. Following the transaction, the chief financial officer now directly owns 87,425 shares in the company, valued at $1,993,290. The disclosure for this sale can be found here. Insiders have sold a total of 136,700 shares of company stock worth $3,140,059 over the last three months. 5.80% of the stock is currently owned by insiders.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Want to see what other hedge funds are holding KTWO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for K2M Group Holdings, Inc. (NASDAQ:KTWO).

Institutional Ownership by Quarter for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Stock Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related stocks with our FREE daily email newsletter.